Crackdown on pharma companies: Licences of 18 pharmaceutical firms cancelled for manufacturing spurious drugs
Central and state regulators conducted joint inspections at 76 pharma companies and cancelled the licences of 18 of them. Twenty-six other companies have been issued show cause notices

The sources said that as part of a special drive, the regulators have identified 203 firms. A majority of the companies are from Himachal Pradesh (70), followed by Uttarakhand (45) and Madhya Pradesh (23). (Photo: Pixabay)